Researchers have developed a dual-functional cell engager that combines cell bridging and targeted chemotherapeutic delivery to improve chimeric antigen receptor T (CAR T) cell therapy for relapsed and refractory leukemias.
A research team led by Prof. BAI Shuo from the Institute of Process Engineering of the Chinese Academy of Sciences has pioneered a fully biodegradable, self-powered implantable electrical stimulation system designed to enhance muscle repair.